Cencora Inc

CORNYSE · USD
306.92USD0.00 (-0.96%)
589

Cencora Inc (COR) Covered Calls

Loading COR covered call opportunities from the prior session (coming three months window)…

Read more

Running COR covered calls helps you generate consistent income from Cencora Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Cencora Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best COR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if COR stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling COR covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Cencora Inc covered call is worth writing.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.

Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Income-focused investors, long-term COR holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling COR covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Cencora Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Distribution
  • SectorHealthcare
  • IV percentile63.89% Neutral
  • Market cap (M$)58,569
  • 52 weeks high-18.71%
  • 52 weeks low25.37%
  • Analyst recommendationBuy
    1.79
  • Target price$368.92
    20.20% above the current stock price
  • Dividend—
  • Payout ratio27.63%
  • Earnings date2026-11-04
  • P/E22.82
  • Future P/E15.49
  • EPS (ttm)13.45
  • EPS growth next 5 years11.09%

As of September 25, 2026

No illustrative rows to display.

As of September 25, 2026

Sell covered calls with the data behind you

Find the best COR covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial